Clinical Trial Update: Virtual Reality Cognitive-Affective Training for Opioid Use Disorder- A Phase 2 RCT [NA]

View source ↗

Summary

An active Phase 2 randomized clinical trial is evaluating virtual reality cognitive-affective training for opioid use disorder, sponsored by BehaVR LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Opioid Use Disorder

Snippet

Sponsor: BehaVR LLC | Conditions: Opioid Use Disorder | NA | Status: ACTIVE_NOT_RECRUITING